Related Articles for PubMed (Select 18598360)

Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells.

Saikali Z, Setya H, Singh G, Persad S.

Cancer Cell Int. 2008 Jul 3;8:10.

PMID: 18598360 [PubMed - in process]

Related Articles Free article in PMC

Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.

Sroka IC, McDaniel K, Nagle RB, Bowden GT.

Prostate. 2008 Apr 1;68(5):463-76.

PMID: 18196535 [PubMed - indexed for MEDLINE]

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.

Jones HE, Goddard L, Gee JM, Hiscox S, Rubini M, Barrow D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI.

Endocr Relat Cancer. 2004 Dec;11(4):793-814.

PMID: 15613453 [PubMed - indexed for MEDLINE]

Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF kappa B.

Vayalil PK, Mittal A, Katiyar SK.

Carcinogenesis. 2004 Jun;25(6):987-95. Epub 2004 Jan 23.

PMID: 14742313 [PubMed - indexed for MEDLINE]

Suppression of type 1 Insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice.

Qian J, Dong A, Kong M, Ma Z, Fan J, Jiang G.

Acta Biochim Biophys Sin (Shanghai). 2007 Feb;39(2):137-47.

PMID: 17277889 [PubMed - indexed for MEDLINE]

Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.

Marelli MM, Moretti RM, Procacci P, Motta M, Limonta P.

Int J Oncol. 2006 Mar;28(3):723-30.

PMID: 16465378 [PubMed - indexed for MEDLINE]

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.

Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P.

J Pathol. 2004 Jan;202(1):50-9.

PMID: 14694521 [PubMed - indexed for MEDLINE]

Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.

Fang J, Zhou Q, Shi XL, Jiang BH.

Carcinogenesis. 2007 Mar;28(3):713-23. Epub 2006 Oct 25.

PMID: 17065200 [PubMed - indexed for MEDLINE]

Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Res Commun Mol Pathol Pharmacol. 2004;115-116:251-64.

PMID: 17564322 [PubMed - indexed for MEDLINE]

10:

Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells.

Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P.

Int J Cancer. 2003 May 20;105(1):14-9.

PMID: 12672024 [PubMed - indexed for MEDLINE]

11:

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR.

Cancer Gene Ther. 2003 Nov;10(11):823-32.

PMID: 14605668 [PubMed - indexed for MEDLINE]

12:

Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.

Stawowy P, Kallisch H, Kilimnik A, Margeta C, Seidah NG, Chrétien M, Fleck E, Graf K.

Biochem Biophys Res Commun. 2004 Aug 27;321(3):531-8.

PMID: 15358140 [PubMed - indexed for MEDLINE]

13:

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.

Darby S, Cross SS, Brown NJ, Hamdy FC, Robson CN.

J Pathol. 2008 Feb;214(3):394-404.

PMID: 18072288 [PubMed - indexed for MEDLINE]

14:

DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.

Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.

Exp Cell Res. 2004 Sep 10;299(1):91-100.

PMID: 15302576 [PubMed - indexed for MEDLINE]

15:

Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.

Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS.

J Biol Chem. 2004 Sep 10;279(37):39042-50. Epub 2004 Jul 9.

PMID: 15247230 [PubMed - indexed for MEDLINE]

16:

3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.

Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI.

BMC Cancer. 2006 Mar 21;6:77.

PMID: 16551362 [PubMed - indexed for MEDLINE]

Recent Activity